MLICM
EXFY icon

Metropolitan Life Insurance Company (MetLife)’s Expensify EXFY Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EXFY Stock Details EXFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,096
Closed -$7.65K – 2318
2023
Q4 		$7.65K Hold
3,096
– – ﹤0.01% 2251
2023
Q3 		$10.1K Hold
3,096
– – ﹤0.01% 2206
2023
Q2 		$24.7K Buy
+3,096
New +$22.7K ﹤0.01% 1818

Other funds holding EXFY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EXFY Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Expensify (EXFY) in Q1 2024, closing a stake of 3,096 shares — an estimated $7.65K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EXFY in Q2 2023 and held it in 3 quarters. The position peaked at $24.7K in Q2 2023. 88 funds tracked by Wall St. Rank hold EXFY as of Q1 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Expensify position as of Q1 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,096 Expensify shares in Q1 2024, an estimated $7.65K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Expensify in Q2 2023 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Expensify position peaked at $24.7K in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Expensify as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.